{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T21:08:01Z","timestamp":1789247281832,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,12]]},"DOI":"10.7759\/cureus.116149","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:58:33Z","timestamp":1789246713000},"source":"Crossref","is-referenced-by-count":0,"title":["Exceptionally Durable Response to First-Line S-1 Monotherapy in Metastatic Pancreatic Adenocarcinoma: A Case Report"],"prefix":"10.7759","author":[{"given":"Takayuki","family":"Ota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Iinuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Suyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy T","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M, et al.. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011, 364:1817-25. 10.1056\/NEJMoa1011923","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff DD","year":"2013","unstructured":"Von Hoff DD, Ervin T, Arena FP, et al.. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013, 369:1691-703. 10.1056\/NEJMoa1304369","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.3680","article-title":"Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study","volume":"31","author":"Ueno H","year":"2013","unstructured":"Ueno H, Ioka T, Ikeda M, et al.. Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study. J Clin Oncol. 2013, 31:1640-8. 10.1200\/JCO.2012.43.3680","journal-title":"J Clin Oncol"},{"key":"ref4","article-title":"Resolution of liver metastases in response to S-1 monotherapy in advanced pancreatic cancer--a case report [Article in Japanese]","volume":"33","author":"Mizuno N","year":"2006","unstructured":"Mizuno N, Sawaki A, Yamao K. Resolution of liver metastases in response to S-1 monotherapy in advanced pancreatic cancer--a case report [Article in Japanese]. Gan To Kagaku Ryoho. 2006, 33:1511-4.","journal-title":"Gan To Kagaku Ryoho"},{"key":"ref5","article-title":"Chemotherapy-na\u00efve advanced pancreatic cancer with multiple liver metastases successfully treated by S-1 monotherapy--a case report [Article in Japanese]","volume":"33","author":"Yoshino T","year":"2006","unstructured":"Yoshino T, Fukutomi A, Boku N. Chemotherapy-na\u00efve advanced pancreatic cancer with multiple liver metastases successfully treated by S-1 monotherapy--a case report [Article in Japanese]. Gan To Kagaku Ryoho. 2006, 33:1521-3.","journal-title":"Gan To Kagaku Ryoho"},{"key":"ref6","article-title":"A case report of complete response to low-dose S-1 monotherapy for pancreatic cancer in elderly patient [Article in Japanese]","volume":"39","author":"Sato R","year":"2012","unstructured":"Sato R, Kawamura M, Kawamura T, Sasaki K, Ushigome T, Nyumura Y. A case report of complete response to low-dose S-1 monotherapy for pancreatic cancer in elderly patient [Article in Japanese]. Gan To Kagaku Ryoho. 2012, 39:2569-71.","journal-title":"Gan To Kagaku Ryoho"},{"key":"ref7","article-title":"A case of pancreatic cancer with multiple liver metastases that developed postoperatively and showed a complete response with S-1 monotherapy [Article in Japanese]","volume":"42","author":"Saso K","year":"2015","unstructured":"Saso K, Murata M, Asai K, et al.. A case of pancreatic cancer with multiple liver metastases that developed postoperatively and showed a complete response with S-1 monotherapy [Article in Japanese]. Gan To Kagaku Ryoho. 2015, 42:1620-2.","journal-title":"Gan To Kagaku Ryoho"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5833\/jjgs.2016.0122","article-title":"Pathological complete response after S-1 therapy for an unresectable pancreatic head cancer with liver metastasis [Article in Japanese]","volume":"50","author":"Miyata T","year":"2017","unstructured":"Miyata T, Okamura Y, Sugiura T, et al.. Pathological complete response after S-1 therapy for an unresectable pancreatic head cancer with liver metastasis [Article in Japanese]. Jpn J Gastroenterol Surg. 2017, 50:461-8. 10.5833\/jjgs.2016.0122","journal-title":"Jpn J Gastroenterol Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s40792-018-0460-1","article-title":"S-1 induced discoid lupus erythematosus-like lesions and long-term complete response for para-aortic lymph node recurrence of pancreatic ductal adenocarcinoma: a case report","volume":"4","author":"Yamaga R","year":"2018","unstructured":"Yamaga R, Tezuka K, Sugawara S, Watanabe T, Hirai I, Suzuki T, Kimura W. S-1 induced discoid lupus erythematosus-like lesions and long-term complete response for para-aortic lymph node recurrence of pancreatic ductal adenocarcinoma: a case report. Surg Case Rep. 2018, 4:52. 10.1186\/s40792-018-0460-1","journal-title":"Surg Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5662\/wjm.v14.i4.93461","article-title":"Role of molecular imaging in prognosis, diagnosis, and treatment of gastrointestinal cancers: an update on new therapeutic methods","volume":"14","author":"Fathi M","year":"2024","unstructured":"Fathi M, Taher HJ, Al-Rubiae SJ, et al.. Role of molecular imaging in prognosis, diagnosis, and treatment of gastrointestinal cancers: an update on new therapeutic methods. World J Methodol. 2024, 14:93461. 10.5662\/wjm.v14.i4.93461","journal-title":"World J Methodol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-025-17319-4","article-title":"Diagnostic value of diffusion-weighted MRI for the detection of peritoneal and liver metastases in high-risk pancreatic ductal adenocarcinoma: a prospective pilot study","volume":"32","author":"Charbonneau J","year":"2025","unstructured":"Charbonneau J, No\u00ebl P, Ouellet JF, et al.. Diagnostic value of diffusion-weighted MRI for the detection of peritoneal and liver metastases in high-risk pancreatic ductal adenocarcinoma: a prospective pilot study. Ann Surg Oncol. 2025, 32:6511-8. 10.1245\/s10434-025-17319-4","journal-title":"Ann Surg Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-024-01866-7","article-title":"MRI analysis of relative tumor enhancement in liver metastases and correlation with immunohistochemical features","volume":"15","author":"Barajas Ordonez F","year":"2024","unstructured":"Barajas Ordonez F, Gottschling S, Eger KI, Borggrefe J, Jechorek D, Surov A. MRI analysis of relative tumor enhancement in liver metastases and correlation with immunohistochemical features. Insights Imaging. 2024, 15:294. 10.1186\/s13244-024-01866-7","journal-title":"Insights Imaging"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2012.709234","article-title":"S-1 for the treatment of gastrointestinal cancer","volume":"13","author":"Satoh T","year":"2012","unstructured":"Satoh T, Sakata Y. S-1 for the treatment of gastrointestinal cancer. Expert Opin Pharmacother. 2012, 13:1943-59. 10.1517\/14656566.2012.709234","journal-title":"Expert Opin Pharmacother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2025.104528","article-title":"ESMO Clinical Practice Guideline Express Update on the management of metastatic pancreatic cancer","volume":"10","author":"Conroy T","year":"2025","unstructured":"Conroy T, Ducreux M. ESMO Clinical Practice Guideline Express Update on the management of metastatic pancreatic cancer. ESMO Open. 2025, 10:104528. 10.1016\/j.esmoop.2025.104528","journal-title":"ESMO Open"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v2.i7.299","article-title":"An oral fluoropyrimidine agent S-1 induced interstitial lung disease: a case report","volume":"2","author":"Yamane H","year":"2011","unstructured":"Yamane H, Kinugawa M, Umemura S, et al.. An oral fluoropyrimidine agent S-1 induced interstitial lung disease: a case report. World J Clin Oncol. 2011, 2:299-302. 10.5306\/wjco.v2.i7.299","journal-title":"World J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/532566-exceptionally-durable-response-to-first-line-s-1-monotherapy-in-metastatic-pancreatic-adenocarcinoma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:58:34Z","timestamp":1789246714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/532566-exceptionally-durable-response-to-first-line-s-1-monotherapy-in-metastatic-pancreatic-adenocarcinoma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.116149","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,12]]}}}